Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc. | 9 | 2 | 1 | 0 | €0.87 | €7.38 | 746.945% |
| Glycomimetics Inc. | 5 | 1 | 0 | 1 | €0.23 | €7.35 | 3138.590% |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | €3.17 | €7.31 | 130.539% |
| Arca Biopharma | 2 | 18 | 2 | 0 | €3.08 | €6.50 | 111.039% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.85 | €6.49 | 661.924% |
| Trevena Inc. | 2 | 17 | 0 | 3 | €0.34 | €6.48 | 1784.302% |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.83 | €5.51 | 564.410% |
| Immunic Inc. | 6 | 3 | 0 | 0 | €1.02 | €5.48 | 437.431% |
| Gritstone Oncology Inc | 4 | 2 | 1 | 0 | €0.72 | €5.07 | 599.310% |
| Cardiff Oncology Inc. | 2 | 4 | 0 | 0 | €2.50 | €5.00 | 100.401% |
| Avinger Inc. | 2 | 5 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Cara Therapeutics Inc. | 11 | 2 | 1 | 1 | €0.23 | €4.61 | 1941.947% |
| Sangamo Therapeutics Inc. | 12 | 12 | 0 | 0 | €0.39 | €3.63 | 825.344% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.51 | €3.00 | 98.216% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| InVivo Therapeutics Holdings | 1 | 16 | 0 | 0 | €0.35 | €1.60 | 359.770% |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €3.58 | - | - |
| Organovo Holdings Inc. | 0 | 7 | 0 | 0 | €0.82 | - | - |
| Minerva Neurosciences Inc. | 0 | 5 | 0 | 2 | €3.38 | - | - |
| NanoVibronix Inc. | 0 | 1 | 0 | 0 | €0.72 | - | - |
| T2 Biosystems Inc. | 0 | 9 | 0 | 0 | €0.16 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.23 | - | - |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €1.00 | - | - |
| BioLase Inc. | 0 | 9 | 0 | 1 | €0.067 | - | - |
| Vaxart Inc. | 0 | 1 | 0 | 0 | €0.64 | - | - |